“Melatonin is a naturally occurring hormone found in all living organisms: human, animals, plants, and microbes. Melatonin is known as N-acetyl-5-methoxytryptamine in chemical terms. It is produced in the pineal gland, which is located in the posterior part of the third ventricle of the human brain. Synthesis and secretion of melatonin is regulated by exposure to light. Melatonin secretion is low during the day, while it is at its peak at night. It plays a significant role in the sleeping pattern of humans. Secretion of melatonin in a human body decreases with age due to gradual calcification of the pineal gland. This phenomenon is responsible for insomnia in the elderly. Melatonin also influences the reproductive cycle in certain animals such as sheep and goats. Global Melatonin Market was valued at just under USD 1,300 million in 2019 and is expected to reach over USD 3,666 million in 2027, growing at a CAGR of over 16% during the forecast period.
By type, global Melatonin market is segmented into Food Grade and Pharmaceutical Grade. In 2020, global Melatonin market was dominated by food grade segment with over 50% share in total revenue generation. It is also expected to be one of the fastest growing segments over the forecast period and maintain its dominance.
Download Free Sample Report @ https://www.eonmarketresearch.com/sample/77318
Global Melatonin market is segmented on the basis of applications such as Dietary supplements, Medicine, Food and beverages and Others. Dietary supplements segment dominated the global Melatonin market with over 50% share in 2020. Retail pharmacy also accounted for significant share in 2020. However, online pharmacy segment is likely to grow at rapid pace over the forecast period. Despite of approval from FDA, Melatonin has not yet used us main drug for the treatment of cancer. It is more likely used as a combination medication along with other mainstream drugs. Food and beverages is another application that has exhibited remarkable market penetration in a few years. It is poised for further growth. However, growth in food and beverages application is subject to FDA approval of use of melatonin as a food supplement.
North America dominated the global Melatonin market in 2019 with over 60% share in total revenue generated by this industry. North America is closely followed by the Europe. However, with rising healthcare expenditure and growing awareness among people regarding healthcare is likely to drive growth of the Melatonin market at rapid pace in Asia Pacific. The primary driver of the melatonin market is the dietary supplements status it experiences in North America. Melatonin is generally used for primary insomnia and sleep related diseases; however, scientific studies suggest that melatonin hormone is also an effective cancer inhibitor, and is useful to fight depression and anxiety. Since its benefits are amply marketed in North America, over-the-counter sales have surged and the melatonin molecule has found reception in the market. Increased stress level among the youth has also contributed to high growth of the melatonin market. The same is not true for other markets such as Europe and Asia Pacific, as melatonin is largely regulated and is available only with medical prescription.
Major players in global Melatonin market include but not limited to Natrol, Inc., Rexall Sundown, Inc., Neurim Pharmaceuticals Ltd, Schiff Nutrition International, Fidia Farmaceutici S.P.A, Flynn Pharma Ltd., Aspen Pharmacare Holdings Ltd., Solal Technologies (Pty) Ltd., Pulse Pharmaceuticals Ltd., Bebida Beverage Co. and Others. The global Melatonin market is highly concentrated with top 3 players accounting for just over 25% share in the global market.
Buy This Premium Report: https://www.eonmarketresearch.com/buy/77318
Melatonin Market by Type, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
• Food Grade
• Pharmaceutical Grade
Melatonin Market by Application, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
• Dietary supplements
• Food and beverages
Melatonin Market by Region, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
• North America
o United States
• Asia Pacific
o South Korea
o Southeast Asia
• Latin America
• Middle East and Africa
o Saudi Arabia
o South Africa
Melatonin Market by Company, 2018 – 2019 Volume (Tons) and Revenue (USD Million)
• Natrol, Inc.
• Rexall Sundown, Inc.
• Neurim Pharmaceuticals Ltd
• Schiff Nutrition International
• Fidia Farmaceutici S.P.A
• Flynn Pharma Ltd.
• Aspen Pharmacare Holdings Ltd.
• Solal Technologies (Pty) Ltd.
• Pulse Pharmaceuticals Ltd.
• Bebida Beverage Co.
Do Inquiry Before Purchasing Report Here and Ask For Discount: https://www.eonmarketresearch.com/enquiry/77318
Explore Related Reports:
- Global Optical DTI Imaging Technology Market
- Global Choline Alfoscerate (Alpha GPC) Market
- Global Bovine Ephemeral Fever Vaccines Market
- Global Cartilage Repair Regeneration Market
- Global Melatonin Market
- Global Liraglutide Injection Market
Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.
Eon Market Research
Phone: +1 703 879 7090